Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders

Raymond R. Tubbs, Hongwei Wang, Zhen Wang, Eugen C. Minca, Bryce P. Portier, Aaron M. Gruver, Christopher Lanigan, Yuling Luo, James R. Cook, Xiao Jun Ma

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

Objectives: To assess the feasibility of using a novel ultrasensitive bright-field in situ hybridization approach (BRISH) to evaluate k and l immunoglobulin messenger RNA (mRNA) expression in situ in B-cell non-Hodgkin lymphoma (NHL). Methods: A series of 110 semiconsecutive clinical cases evaluated for lymphoma with historic flow cytometric (FCM) results were assessed with BRISH. Results: BRISH light chain restriction (LCR) results were concordant with FCM in 108 (99%) of 109 evaluable cases. Additional small B-cell lymphoma cohorts were successfully evaluated. Conclusions: BRISH analysis of k and l immunoglobulin mRNA expression is a sensitive tool for establishing LCR in B-cell NHL when FCM results are not available.

Original languageEnglish (US)
Pages (from-to)736-746
Number of pages11
JournalAmerican Journal of Clinical Pathology
Volume140
Issue number5
DOIs
StatePublished - Nov 2013

Keywords

  • B-cell clonality
  • B-cell lymphoma
  • BRISH
  • CISH
  • In situ hybridization
  • RNAscope

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders'. Together they form a unique fingerprint.

Cite this